3-O-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-Lribo-hexopyranosyl)erythromycin 9-(E)-[O-[(2- methoxyethoxy)methyl]oxime]; (9E)-3-O-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)erythromycin9-[O-[(2-Methoxyethoxy)methyl]oxime];Decladinoseroxithromycin; (9E)-3-O-De(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)erythromycin 9-[O-[(2-Methoxyethoxy)methyl]oxime]; Decladinose Roxithromycin
Roxithromycin EP Impurity B is a fully characterized chemical compound used as a reference standard of API Roxithromycin. The standard offered is compliant with regulatory guidelines. Roxithromycin EP Impurity B is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 214902-82-6
Related products
Roxithromycin Impurity 5 (1-(2-Methoxyethoxy) Methanol)
M.F.
M.W. 106.063
CAT# AR-R11637
CAS# 67796-27-4
